Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Am J Transplant. 2011 Jun 10;11(7):1464–1477. doi: 10.1111/j.1600-6143.2011.03572.x

Figure 7.

Figure 7

Cell quantitation statistics for the engraftment syndrome (ES) and the following controls: acute cellular rejection, type II (ACR2), acute tubular injury (ATI), and normal (Nml), with respect to the number of cells positive for Ki67, CD68, and CD3 in the glomeruli, tubules, and interstitium, respectively. Lines and numbers denote statistically significant relationships and the corresponding p value. ES is distinguished from ACR2 by increased CD3+, Ki67+ and CD68+ cells in glomeruli and decreased CD3+, Ki67+ and CD68+ cells in tubules, as well as decreased numbers of CD3 cells in PTC/interstitium. ES is distinguished from ATI by increased CD3+, Ki67+ cells in glomeruli, and from normal kidneys by the same as well as CD68+ cells in the PTC/interstitium.